Open access
Sep 2026
Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.
Not available.
Juanjuan Li, M. Yue, Yu-Chun Yan et al.
· Haematologica · 0 citations